Profound Medical Corp. - PROF

SEC FilingsOur PROF Tweets

About Gravity Analytica

Recent News

  • 02.12.2026 - Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow
  • 02.12.2026 - Profound Medical Honored with INOVAIT’s 2025–2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease
  • 02.05.2026 - PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women’s Health
  • 01.27.2026 - Profound Medical Announces Upcoming Investor Events
  • 01.15.2026 - Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®
  • 01.12.2026 - Profound Surpasses 2025 TULSA-PRO® Installed Base Goal
  • 01.06.2026 - Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case
  • 12.30.2025 - Profound Medical Corp. Announces Closing of Private Placement

Recent Filings

  • 02.05.2026 - EX-99.1 EX-99.1
  • 02.05.2026 - 8-K Current report
  • 01.28.2026 - EX-99.1 EX-99.1
  • 01.28.2026 - 8-K Current report
  • 01.15.2026 - 8-K Current report
  • 01.15.2026 - EX-99.1 EX-99.1
  • 01.12.2026 - EX-99.1 EX-99.1
  • 01.12.2026 - 8-K Current report
  • 01.06.2026 - 8-K Current report
  • 01.06.2026 - EX-99.1 EX-99.1